Teva Pharmaceutical Indus... (TEVA)

AI Score

Unlock

15.49

-0.20 (-1.27%)

At close: Mar 27, 2025, 3:59 PM

15.63

0.90%

After-hours: Mar 27, 2025, 08:00 PM EDT

Teva Pharmaceutical Industries Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY00	FY99	FY98	FY97	FY96	FY95	FY94	FY93	FY92	FY91	FY90	FY89	FY88	FY86	FY85
Revenue	16.54B	15.85B	14.93B	15.88B	16.66B	16.89B	18.85B	22.39B	21.9B	19.65B	20.27B	20.31B	20.32B	18.31B	16.12B	13.9B	11.09B	9.41B	8.41B	5.25B	4.8B	3.28B	2.52B	2.08B	1.75B	1.28B	1.12B	1.12B	953.8M	667.7M	587.7M	502M	406.7M	327.1M	329M	281.1M	211.1M	139.6M	91.2M
Cost of Revenue	8.48B	8.2B	7.95B	8.28B	8.93B	9.35B	10.56B	11.56B	10.04B	8.3B	9.22B	9.61B	9.66B	8.8B	7.06B	6.53B	5.12B	4.53B	4.15B	2.77B	2.56B	1.76B	1.42B	1.23B	962.99M	699.2M	636.1M	628.9M	550.4M	364.1M	305.7M	268.5M	229.8M	194.1M	191.3M	180.7M	129.5M	84.9M	58.8M
Gross Profit	8.06B	7.65B	6.97B	7.59B	7.72B	7.54B	8.3B	10.82B	11.86B	11.36B	11.06B	10.71B	10.65B	9.52B	9.06B	7.37B	5.97B	4.88B	4.26B	2.48B	2.24B	1.52B	1.1B	847.29M	786.86M	583.2M	479.8M	488M	403.4M	303.6M	282M	233.5M	176.9M	133M	137.7M	100.4M	81.6M	54.7M	32.4M
Operating Income	-303M	433M	2.8B	3.2B	3.05B	2.8B	-1.64B	-17.48B	2.15B	3.35B	3.95B	1.65B	2.21B	3.11B	3.87B	2.4B	1.15B	2.4B	801M	1.31B	577.8M	877.4M	524M	360.79M	244.53M	199.05M	145M	173.8M	129.3M	115.2M	106.7M	88M	56M	52.1M	40.3M	44.2M	22.5M	19.3M	11.9M
Interest Income	-48M	68M	920M	891M	24M	41M	n/a	3M	n/a	53M	n/a	n/a	329M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-1.28B	-624M	-3.06B	658M	-4.41B	-1.26B	-2.6B	-18.38B	824M	2.35B	3.64B	1.25B	1.82B	2.96B	3.65B	2.2B	827M	2.35B	706M	1.31B	603.7M	872.4M	499.4M	341.86M	207.99M	162.17M	99.7M	140.2M	94.3M	107.7M	98.6M	85M	52.6M	37M	30.5M	25.1M	19.1M	22M	12.9M
Net Income	-1.64B	-559M	-2.35B	417M	-3.99B	-999M	-2.15B	-16.27B	329M	1.59B	3.06B	1.27B	1.96B	2.76B	3.33B	2B	635M	1.95B	546M	1.07B	331.8M	691M	410.3M	278.21M	148.42M	117.83M	68.8M	101.5M	73.4M	79.8M	71.6M	57.5M	32.6M	23.7M	20.8M	16.9M	12M	14.8M	7.6M
Selling & General & Admin	3.7B	3.5B	3.44B	3.53B	3.67B	3.81B	4.21B	4.99B	5.1B	4.72B	5.08B	5.32B	5.12B	4.41B	3.83B	3.5B	2.51B	1.9B	1.57B	798.8M	696.5M	520.6M	406.4M	363.56M	307.08M	233.89M	208M	197M	167.6M	131.4M	115.2M	125.9M	102.3M	67.1M	84.8M	56.1M	51.3M	30.3M	17M
Research & Development	998M	953M	838M	967M	997M	1.01B	1.21B	1.85B	2.11B	1.52B	1.49B	1.43B	1.36B	1.09B	933M	802M	786M	581M	495M	368.9M	338.4M	213.5M	165M	107.27M	104.58M	81.84M	68.1M	65.2M	62.8M	31.6M	36.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	3.67B	2.76B	107M	98M	-4M	76M	291M	1.2B	636M	23M	-17M	-36M	40M	n/a	n/a	n/a	n/a	n/a	96M	54.3M	30M	-100M	n/a	n/a	n/a	68.42M	58.7M	52M	43.7M	25.4M	23.5M	19.6M	18.6M	13.8M	12.6M	100K	7.8M	5.1M	3.5M
Operating Expenses	8.37B	7.21B	4.28B	4.5B	4.67B	4.82B	5.43B	6.83B	7.21B	6.24B	6.57B	6.75B	6.47B	5.5B	4.77B	4.3B	4.82B	2.48B	2.16B	1.17B	1.06B	634.1M	571.4M	470.84M	411.65M	384.16M	334.8M	314.2M	274.1M	188.4M	175.3M	145.5M	120.9M	80.9M	97.4M	56.2M	59.1M	35.4M	20.5M
Interest Expense	1B	1.03B	966M	1.06B	963M	822M	881M	895M	1.33B	1B	276M	282M	n/a	153M	225M	230M	318M	n/a	2.7B	4.4M	1.2B	n/a	16.8M	43.13M	193.07M	44.35M	67.3M	42.9M	46M	7.4M	5.1M	500K	2.7M	14.2M	8.4M	25.8M	2.4M	n/a	n/a
Selling & Marketing Expenses	2.54B	2.34B	2.27B	2.43B	2.5B	2.61B	2.92B	3.66B	3.86B	3.48B	3.86B	4.08B	3.88B	3.48B	2.97B	2.68B	1.84B	n/a	n/a	322.31M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	16.85B	15.41B	12.23B	12.78B	13.6B	14.17B	15.98B	18.39B	17.25B	14.54B	15.78B	16.35B	16.14B	14.3B	11.82B	10.83B	9.94B	7.01B	6.31B	3.94B	3.62B	2.39B	1.99B	1.7B	1.37B	1.08B	970.9M	943.1M	824.5M	552.5M	481M	414M	350.7M	275M	288.7M	236.9M	188.6M	120.3M	79.3M
Income Tax	355M	-7M	-638M	211M	-168M	-278M	-195M	-1.93B	521M	634M	591M	-43M	-137M	127M	283M	166M	185M	397M	155M	236.2M	267.2M	181.5M	84.8M	63.65M	59.57M	44.34M	30.9M	38.7M	20.9M	27.9M	27M	27.5M	20M	13.3M	9.7M	8.2M	7.1M	7.2M	5.3M
Shares Outstanding (Basic)	1.13B	1.12B	1.11B	1.1B	1.09B	1.09B	1.02B	1.02B	955M	855M	853M	849M	872M	890M	896M	872M	780M	768M	756M	618M	612.7M	536.8M	529M	529.93M	516.23M	491.7M	488.3M	489.16M	489.33M	484.83M	482.86M	425.93M	409.03M	364.62M	396.19M	338M	342.86M	436.91M	436.91M
Shares Outstanding (Diluted)	1.13B	1.12B	1.11B	1.11B	1.09B	1.09B	1.02B	1.02B	961M	864M	858M	850M	873M	893M	921M	896M	820M	830M	805M	681M	688M	590M	561.6M	545.51M	520.76M	491.7M	488.3M	489.16M	489.33M	484.83M	482.86M	425.93M	409.03M	412.17M	396.19M	338M	342.86M	436.91M	436.91M
EPS (Basic)	-1.45	-0.5	-2.12	0.38	-3.64	-0.92	-2.11	-16.01	0.07	1.84	3.58	1.49	2.25	3.10	3.72	2.29	0.81	2.54	0.72	1.73	0.54	1.29	0.78	0.53	0.29	0.24	0.14	0.21	0.15	0.14	0.14	0.14	0.08	0.07	0.05	0.05	0.04	0.03	0.02
EPS (Diluted)	-1.45	-0.5	-2.12	0.38	-3.64	-0.92	-2.11	-16.01	0.07	1.82	3.56	1.49	2.25	3.09	3.67	2.23	0.78	2.38	0.69	1.59	0.50	1.20	0.76	0.51	0.28	0.24	0.14	0.21	0.15	0.14	0.14	0.14	0.08	0.06	0.05	0.05	0.04	0.03	0.02
EBITDA	-303M	1.57B	-874M	4.41B	-2.09B	1.28B	186M	-15.52B	2.87B	6.34B	5.97B	3.21B	3.88B	4.26B	4.83B	2.4B	1.15B	2.4B	2.53B	1.55B	1.39B	1.01B	524M	485.58M	470.19M	335.89M	262.48M	225.8M	173M	137.2M	134.3M	107.6M	72.8M	65.9M	52.9M	44.3M	30.3M	24.4M	15.4M
Depreciation & Amortization	n/a	1.15B	1.31B	1.33B	1.56B	1.72B	1.84B	2.08B	1.49B	1.31B	1.51B	1.64B	1.71B	1.07B	977M	908M	493M	521M	431M	242.5M	220.4M	127.7M	96.9M	109.13M	94.98M	68.42M	58.7M	52M	43.7M	25.4M	23.5M	19.6M	18.6M	13.8M	12.6M	100K	7.8M	5.1M	3.5M